Thompson Siegel & Walmsley LLC Sells 314,937 Shares of Herbalife Ltd $HLF

Thompson Siegel & Walmsley LLC cut its holdings in shares of Herbalife Ltd (NYSE:HLFFree Report) by 44.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 386,387 shares of the company’s stock after selling 314,937 shares during the period. Thompson Siegel & Walmsley LLC owned about 0.37% of Herbalife worth $4,981,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of HLF. Aster Capital Management DIFC Ltd bought a new position in shares of Herbalife in the 3rd quarter valued at $35,000. Advisory Services Network LLC bought a new stake in Herbalife during the third quarter valued at $65,000. Quarry LP boosted its position in shares of Herbalife by 49,105.3% during the 3rd quarter. Quarry LP now owns 9,349 shares of the company’s stock worth $79,000 after purchasing an additional 9,330 shares in the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Herbalife by 512.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 6,544 shares of the company’s stock worth $84,000 after purchasing an additional 5,476 shares in the last quarter. Finally, Lazard Asset Management LLC boosted its position in shares of Herbalife by 30.4% during the 3rd quarter. Lazard Asset Management LLC now owns 13,346 shares of the company’s stock worth $113,000 after purchasing an additional 3,112 shares in the last quarter.

Insider Activity

In related news, insider Frank Lamberti sold 134,982 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the transaction, the insider owned 36,624 shares in the company, valued at $494,424. The trade was a 78.66% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Troy Hicks sold 38,377 shares of the business’s stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $12.93, for a total transaction of $496,214.61. Following the transaction, the chief operating officer owned 9,062 shares in the company, valued at $117,171.66. This represents a 80.90% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 191,296 shares of company stock worth $2,551,678 in the last quarter. 5.13% of the stock is owned by corporate insiders.

Herbalife Stock Down 0.4%

Herbalife stock opened at $11.91 on Tuesday. The company has a market capitalization of $1.24 billion, a PE ratio of 5.23, a P/E/G ratio of 0.71 and a beta of 0.89. The firm has a fifty day simple moving average of $14.55 and a two-hundred day simple moving average of $14.78. Herbalife Ltd has a twelve month low of $7.36 and a twelve month high of $20.40.

Herbalife (NYSE:HLFGet Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.30 billion. During the same quarter in the previous year, the company earned $0.59 earnings per share. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. As a group, equities analysts expect that Herbalife Ltd will post 2.47 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on HLF shares. Royal Bank Of Canada lowered their target price on shares of Herbalife from $17.00 to $16.00 and set a “sector perform” rating on the stock in a report on Tuesday, April 28th. Mizuho set a $17.00 price objective on shares of Herbalife in a research note on Monday, May 4th. Weiss Ratings lowered shares of Herbalife from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 22nd. Zacks Research lowered shares of Herbalife from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 20th. Finally, Citigroup reaffirmed a “buy” rating and issued a $21.00 price target (up from $17.00) on shares of Herbalife in a report on Thursday, February 19th. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $17.80.

Read Our Latest Stock Analysis on Herbalife

Herbalife Company Profile

(Free Report)

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.

See Also

Institutional Ownership by Quarter for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.